[go: up one dir, main page]

EA201070813A1 - Производные n-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и применение в терапии - Google Patents

Производные n-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и применение в терапии

Info

Publication number
EA201070813A1
EA201070813A1 EA201070813A EA201070813A EA201070813A1 EA 201070813 A1 EA201070813 A1 EA 201070813A1 EA 201070813 A EA201070813 A EA 201070813A EA 201070813 A EA201070813 A EA 201070813A EA 201070813 A1 EA201070813 A1 EA 201070813A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
hydrogen atom
therapy
group
nrr
Prior art date
Application number
EA201070813A
Other languages
English (en)
Inventor
Жан-Франсуа Пэронель
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39712153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201070813(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA201070813A1 publication Critical patent/EA201070813A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединения формулы (I), где Х означает гетероцикл; Rпредставляет собой атом водорода, атом галогена, (C-С)алкоксигруппу, (С-С)алкил, группу NRaRb; Rпредставляет собой атом водорода, замещенный при необходимости (C-C)алкил, замещенную при необходимости (C-C)алкоксигруппу, (С-С)алкенил, (С-С)алкинил, -CO-R, -CO-NRR, -CO-O-R, -NR-CO-R, -NRR, -N=CH-NRaRb, атом галогена, циано-, нитрогруппу, гидроксииминоалкил, алкоксииминоалкил, (C-C)алкилтиогруппу, (C-С) алкилсульфинил, (C-C)алкилсульфонил, ((C-С)алкил))силилэтинил, -SO-NRR, замещенный при необходимости фенил; Rпредставляет собой атом водорода, (С-С)алкил, (C-С)алкоксигруппу или атом галогена; Rпредставляет собой атом водорода, (C-C)алкил, (C-C)алкоксигруппу или атом фтора; в виде основания или кислотно-аддитивной соли. Применение в терапии.
EA201070813A 2008-01-02 2008-12-31 Производные n-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и применение в терапии EA201070813A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800003A FR2925901B1 (fr) 2008-01-02 2008-01-02 DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001834 WO2009106749A2 (fr) 2008-01-02 2008-12-31 Dérivés de n-heterocyclique-imidazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
EA201070813A1 true EA201070813A1 (ru) 2010-12-30

Family

ID=39712153

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070813A EA201070813A1 (ru) 2008-01-02 2008-12-31 Производные n-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и применение в терапии

Country Status (20)

Country Link
US (1) US20100317673A1 (ru)
EP (1) EP2225242A2 (ru)
JP (1) JP2011509250A (ru)
KR (1) KR20100099244A (ru)
CN (1) CN101910172A (ru)
AR (1) AR070072A1 (ru)
AU (1) AU2008351927A1 (ru)
BR (1) BRPI0821992A2 (ru)
CA (1) CA2710860A1 (ru)
CL (1) CL2008003933A1 (ru)
CO (1) CO6331306A2 (ru)
EA (1) EA201070813A1 (ru)
FR (1) FR2925901B1 (ru)
IL (1) IL206671A0 (ru)
MA (1) MA32059B1 (ru)
MX (1) MX2010007349A (ru)
TW (1) TW200934777A (ru)
UY (2) UY3816Q (ru)
WO (1) WO2009106749A2 (ru)
ZA (1) ZA201004643B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2903108B1 (fr) * 2006-07-03 2008-08-29 Sanofi Aventis Sa Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
TWI527813B (zh) 2010-12-13 2016-04-01 亞雷生物製藥股份有限公司 作為III型受體酪胺酸激酶抑制劑之經取代N-(1H-吲唑-4-基)咪唑并 [1,2-a]吡啶-3-甲醯胺化合物
WO2012147890A1 (ja) * 2011-04-27 2012-11-01 持田製薬株式会社 新規アゾール誘導体
JP6284490B2 (ja) 2012-12-28 2018-02-28 株式会社新日本科学 イミダゾピリジン誘導体を有効成分として含むoct3活性阻害剤又はoct3検出剤
EP3946618A1 (en) 2019-04-05 2022-02-09 Storm Therapeutics Ltd Mettl3 inhibitory compounds
WO2022074379A1 (en) * 2020-10-06 2022-04-14 Storm Therapeutics Limited Mettl3 inhibitory compounds
EP4596548A1 (en) * 2024-02-05 2025-08-06 Ludwig-Maximilians-Universität Nurr1 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
US7544803B2 (en) * 2004-01-23 2009-06-09 Amgen Inc. Vanilloid receptor ligands and their use in treatments
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
JP5358962B2 (ja) * 2007-02-06 2013-12-04 住友化学株式会社 組成物及び該組成物を用いてなる発光素子
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Also Published As

Publication number Publication date
MA32059B1 (fr) 2011-02-01
EP2225242A2 (fr) 2010-09-08
US20100317673A1 (en) 2010-12-16
CL2008003933A1 (es) 2010-02-12
JP2011509250A (ja) 2011-03-24
ZA201004643B (en) 2011-09-28
WO2009106749A2 (fr) 2009-09-03
CO6331306A2 (es) 2011-10-20
WO2009106749A3 (fr) 2010-05-06
AR070072A1 (es) 2010-03-10
BRPI0821992A2 (pt) 2015-06-23
MX2010007349A (es) 2010-08-18
IL206671A0 (en) 2010-12-30
UY31587A1 (es) 2009-08-03
AU2008351927A1 (en) 2009-09-03
CN101910172A (zh) 2010-12-08
CA2710860A1 (fr) 2009-09-03
FR2925901B1 (fr) 2011-03-04
FR2925901A1 (fr) 2009-07-03
UY3816Q (es) 2008-09-30
KR20100099244A (ko) 2010-09-10
TW200934777A (en) 2009-08-16

Similar Documents

Publication Publication Date Title
EA201070813A1 (ru) Производные n-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и применение в терапии
GEP201706728B (en) Noxious organism control agent
EA201070817A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
ATE442356T1 (de) 1-essigsäureindolderivate mit pgd2- antagonistischer wirkung
EA200700099A1 (ru) Производные пиридина
WO2009156861A8 (en) Substituted pyrimidone derivatives
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
WO2010010288A3 (fr) Derives de carbamates d' alkylthiazoles, leur preparation et leur utilisation comme inhbiteurs de l'enzyme faah
PE20110582A1 (es) Arilciclohexileteres de dihidro-tetraazabenzoazuleno
EA201000619A1 (ru) Новые производные имидазола
NO20072053L (no) Nye bis-azaindolderivater, fremstilling og farmasoytisk anvendelse derav som kinaseinhibitorer
EA201171385A1 (ru) Производные циклопента[с]пирролилалкилкарбаматов 5-членных гетероциклов, способ их получения и применение их в терапии
MY148504A (en) Compounds which have activity at m? receptor and their uses in medicine
EA200901038A1 (ru) Пестицидные смеси
MX2010012421A (es) 5-[5-[2-(3,5-bis(trifluormetil)fenil)-2-metilpropanoilmetilamino] -4-(4-fluoro-2-metilfenil)]-2-piridinil-2-alquil-prolinamida como antagosnistas del receptor de neurocinina 1.
CY1112638T1 (el) Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον
EA201000604A1 (ru) Новые производные имидазола
EA201070819A1 (ru) Соединения n-фенилимидазо[1,2-a]пиридин-2-карбоксамида, их получение и их применени в терапии
MY155468A (en) Derivatives of 6-heterocyclic-imidazo[l,2-a] pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
EA201070816A1 (ru) Производные n-фенилимидазо[1,2-a]пиридин-2-карбоксамидов, их получение и их применение в терапии
WO2006133928A3 (en) Use of phenylsemicarbazones for seed treatment
WO2009106752A3 (fr) Derives de 2-heteroaroyl-imidazol[1,2-a]pyridine, leur preparation et leur application en therapeutique
EA201070818A1 (ru) ПРОИЗВОДНЫЕ N-ГЕТЕРОЦИКЛИЧЕСКИХ-6-ГЕТЕРОЦИКЛИЧЕСКИХ-ИМИДАЗО[1,2a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
EA200800465A1 (ru) Пестицидные смеси, включающие фенилсемикарбазон